Bio-Thera Solutions Announces Positive Results from Phase 3 Study of BAT2206, a Proposed Biosimilar Referencing Stelara®

The clinical comparative study met its primary endpoint and showed similar efficacy and comparable safety profile in patients with moderate to severe plaque psoriasis GUANGZHOU, China, Nov. 29, 2023 /PRNewswire/ — Bio-Thera Solutions, Ltd. (688177:SH), a commercial-stage…